Delivery Order SPE2DB20D1100-SPE2DB25FA6D9

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,952.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for varenicline 1 mg tablets, a medication used to treat nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award for $2,073.75 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a firm-fixed price delivery order for the supply of 56 tablets of 1 mg Varenicline, a medication used to treat nicotine addiction. The contract has an ultimate completion date of July 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,682.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,962,931 units of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 17, 2025. This award is not associated with a...
This federal contract award, valued at $1,871.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,249.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARENICLINE 1 MG TABLET 56S, a medication used to treat nicotine addiction. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $2,375.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 1 mg tablets, a medication commonly used to treat nicotine addiction. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is open to full...
This federal contract award, valued at $2,877.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 56 tablets of the drug varenicline 1 mg, which is used to treat nicotine addiction. The contract does not have a set-aside designation, indicating open competition. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $1,205.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARENICLINE 0.5 MG TABLET 56S, a medication used in the treatment of tobacco dependence. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical division, valued at $999,999,999 and...
This federal contract award, valued at $1,568.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 0.5 mg tablets, a medication used to treat nicotine addiction. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 and running through November 2026....
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,097.60 and a performance period extending through April 28, 2025. It is not designated as a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA6D9
    Delivery Order

This federal contract award, valued at $7,142.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Varenicline 1 mg tablets, a medication used to treat nicotine addiction.

The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 6:26 AM